

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cysteine metabolic process (GO:0006534) | 9.82570586 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 9.16356731 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 8.91527646 |
| 4 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 8.81540130 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 8.58883037 |
| 6 | glycolipid catabolic process (GO:0019377) | 8.01803582 |
| 7 | amino sugar catabolic process (GO:0046348) | 7.96990189 |
| 8 | glucosamine-containing compound catabolic process (GO:1901072) | 7.34342517 |
| 9 | ceramide catabolic process (GO:0046514) | 7.21525854 |
| 10 | iron ion import (GO:0097286) | 6.97442590 |
| 11 | regulation of cholesterol storage (GO:0010885) | 6.32747316 |
| 12 | positive regulation of bone resorption (GO:0045780) | 6.15035615 |
| 13 | positive regulation of bone remodeling (GO:0046852) | 6.15035615 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.11039301 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 6.11039301 |
| 16 | serine family amino acid catabolic process (GO:0009071) | 6.04917716 |
| 17 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 5.95754616 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 5.76985528 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.76985528 |
| 20 | ganglioside metabolic process (GO:0001573) | 5.54449278 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.51035979 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 5.20196433 |
| 23 | sphingolipid catabolic process (GO:0030149) | 5.13493445 |
| 24 | membrane lipid catabolic process (GO:0046466) | 5.00835050 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.91639682 |
| 26 | creatine metabolic process (GO:0006600) | 4.91008619 |
| 27 | cellular modified amino acid catabolic process (GO:0042219) | 4.90162009 |
| 28 | ectodermal placode formation (GO:0060788) | 4.85964918 |
| 29 | valine metabolic process (GO:0006573) | 4.83323071 |
| 30 | response to thyroid hormone (GO:0097066) | 4.78656963 |
| 31 | glutamate metabolic process (GO:0006536) | 4.76683436 |
| 32 | osteoclast differentiation (GO:0030316) | 4.74974798 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.74846641 |
| 34 | serine family amino acid metabolic process (GO:0009069) | 4.72926588 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.64921172 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 4.64483628 |
| 37 | tryptophan catabolic process (GO:0006569) | 4.62363697 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 4.62363697 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 4.62363697 |
| 40 | regulation of monocyte differentiation (GO:0045655) | 4.52793061 |
| 41 | protein carboxylation (GO:0018214) | 4.51072768 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.51072768 |
| 43 | tryptophan metabolic process (GO:0006568) | 4.49201351 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 4.44439630 |
| 45 | urea cycle (GO:0000050) | 4.41006310 |
| 46 | urea metabolic process (GO:0019627) | 4.41006310 |
| 47 | glyoxylate metabolic process (GO:0046487) | 4.36716333 |
| 48 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.35221482 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 4.35157728 |
| 50 | complement activation, alternative pathway (GO:0006957) | 4.31543586 |
| 51 | lysine metabolic process (GO:0006553) | 4.30938576 |
| 52 | lysine catabolic process (GO:0006554) | 4.30938576 |
| 53 | mannose metabolic process (GO:0006013) | 4.29346087 |
| 54 | oxaloacetate metabolic process (GO:0006107) | 4.23924639 |
| 55 | trivalent inorganic cation transport (GO:0072512) | 4.21524928 |
| 56 | ferric iron transport (GO:0015682) | 4.21524928 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.20340784 |
| 58 | regulation of protein activation cascade (GO:2000257) | 4.19291406 |
| 59 | N-acetylneuraminate metabolic process (GO:0006054) | 4.18987020 |
| 60 | endocardial cushion morphogenesis (GO:0003203) | 4.17546176 |
| 61 | serine family amino acid biosynthetic process (GO:0009070) | 4.16299433 |
| 62 | response to lipoprotein particle (GO:0055094) | 4.13237220 |
| 63 | 2-oxoglutarate metabolic process (GO:0006103) | 4.13077496 |
| 64 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.11492830 |
| 65 | regulation of fibrinolysis (GO:0051917) | 4.09629861 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 4.05803236 |
| 67 | intracellular pH reduction (GO:0051452) | 4.04984020 |
| 68 | peptide catabolic process (GO:0043171) | 4.01528495 |
| 69 | nitrogen cycle metabolic process (GO:0071941) | 3.99868253 |
| 70 | homocysteine metabolic process (GO:0050667) | 3.94853675 |
| 71 | regulation of complement activation (GO:0030449) | 3.94137410 |
| 72 | anterior/posterior axis specification, embryo (GO:0008595) | 3.90747256 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.86526827 |
| 74 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.86505096 |
| 75 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.85816095 |
| 76 | pH reduction (GO:0045851) | 3.85148845 |
| 77 | keratan sulfate catabolic process (GO:0042340) | 3.85142509 |
| 78 | bile acid metabolic process (GO:0008206) | 3.84409314 |
| 79 | reverse cholesterol transport (GO:0043691) | 3.84178661 |
| 80 | transferrin transport (GO:0033572) | 3.75725030 |
| 81 | positive regulation of tissue remodeling (GO:0034105) | 3.71902163 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 3.69883561 |
| 83 | protein-lipid complex remodeling (GO:0034368) | 3.68233406 |
| 84 | macromolecular complex remodeling (GO:0034367) | 3.68233406 |
| 85 | plasma lipoprotein particle remodeling (GO:0034369) | 3.68233406 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 3.65847918 |
| 87 | response to nitrosative stress (GO:0051409) | 3.63653811 |
| 88 | amino-acid betaine metabolic process (GO:0006577) | 3.62248231 |
| 89 | tyrosine metabolic process (GO:0006570) | 3.59959661 |
| 90 | negative regulation of lipase activity (GO:0060192) | 3.59594258 |
| 91 | regulation of plasminogen activation (GO:0010755) | 3.59368253 |
| 92 | negative regulation of sterol transport (GO:0032372) | 3.58437658 |
| 93 | negative regulation of cholesterol transport (GO:0032375) | 3.58437658 |
| 94 | phagosome maturation (GO:0090382) | 3.57067376 |
| 95 | ethanol oxidation (GO:0006069) | 3.52966336 |
| 96 | barbed-end actin filament capping (GO:0051016) | 3.51458787 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 3.51118540 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50793145 |
| 99 | sulfur amino acid metabolic process (GO:0000096) | 3.48093145 |
| 100 | apoptotic cell clearance (GO:0043277) | 3.44031276 |
| 101 | coenzyme catabolic process (GO:0009109) | 3.42533757 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.42367411 |
| 103 | organic acid catabolic process (GO:0016054) | 3.42367411 |
| 104 | glycine metabolic process (GO:0006544) | 3.41371449 |
| 105 | positive regulation of osteoclast differentiation (GO:0045672) | 3.41279798 |
| 106 | vitamin D metabolic process (GO:0042359) | 3.39733869 |
| 107 | cellular ketone body metabolic process (GO:0046950) | 3.38027266 |
| 108 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.37730190 |
| 109 | short-chain fatty acid metabolic process (GO:0046459) | 3.37154535 |
| 110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.35586650 |
| 111 | COPI coating of Golgi vesicle (GO:0048205) | 3.33160862 |
| 112 | Golgi transport vesicle coating (GO:0048200) | 3.33160862 |
| 113 | phospholipid efflux (GO:0033700) | 3.33147068 |
| 114 | lipoprotein metabolic process (GO:0042157) | 3.32617374 |
| 115 | sodium-independent organic anion transport (GO:0043252) | 3.32291574 |
| 116 | benzene-containing compound metabolic process (GO:0042537) | 3.32131679 |
| 117 | fibrinolysis (GO:0042730) | 3.32126409 |
| 118 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.32056500 |
| 119 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.32056500 |
| 120 | fructose metabolic process (GO:0006000) | 3.31156960 |
| 121 | hormone catabolic process (GO:0042447) | 3.29967886 |
| 122 | positive regulation of leukocyte degranulation (GO:0043302) | 3.29600959 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.29401465 |
| 124 | bile acid and bile salt transport (GO:0015721) | 3.29311197 |
| 125 | acylglycerol homeostasis (GO:0055090) | 3.29077699 |
| 126 | triglyceride homeostasis (GO:0070328) | 3.29077699 |
| 127 | iron ion transport (GO:0006826) | 3.27106428 |
| 128 | branched-chain amino acid metabolic process (GO:0009081) | 3.27002748 |
| 129 | positive regulation of mast cell activation (GO:0033005) | 3.26302896 |
| 130 | cholesterol efflux (GO:0033344) | 3.26247592 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 3.25639173 |
| 132 | indolalkylamine metabolic process (GO:0006586) | 3.25510380 |
| 133 | aspartate family amino acid catabolic process (GO:0009068) | 3.23233003 |
| 134 | regulation of receptor binding (GO:1900120) | 3.22796041 |
| 135 | regulation of bone resorption (GO:0045124) | 3.22107262 |
| 136 | N-glycan processing (GO:0006491) | 3.21011260 |
| 137 | regulation of mononuclear cell migration (GO:0071675) | 3.20722300 |
| 138 | plasma lipoprotein particle clearance (GO:0034381) | 3.20146828 |
| 139 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19885898 |
| 140 | arginine metabolic process (GO:0006525) | 3.19850492 |
| 141 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14210722 |
| 142 | sulfur amino acid biosynthetic process (GO:0000097) | 3.13575264 |
| 143 | mesenchyme morphogenesis (GO:0072132) | 3.13455138 |
| 144 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.12868296 |
| 145 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.12863618 |
| 146 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10547157 |
| 147 | cellular glucuronidation (GO:0052695) | 3.09100105 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 3.08091724 |
| 149 | cytolysis (GO:0019835) | 3.04686286 |
| 150 | myeloid dendritic cell differentiation (GO:0043011) | 3.03757700 |
| 151 | acetyl-CoA metabolic process (GO:0006084) | 3.02762417 |
| 152 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.02675454 |
| 153 | succinate metabolic process (GO:0006105) | 3.01731744 |
| 154 | positive regulation of mast cell degranulation (GO:0043306) | 3.00127495 |
| 155 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.00127495 |
| 156 | response to acidic pH (GO:0010447) | 2.99837841 |
| 157 | amine catabolic process (GO:0009310) | 2.99737384 |
| 158 | lipoprotein transport (GO:0042953) | 2.99204319 |
| 159 | amyloid precursor protein catabolic process (GO:0042987) | 2.97548570 |
| 160 | nucleoside transmembrane transport (GO:1901642) | 2.95298535 |
| 161 | negative regulation of lipid storage (GO:0010888) | 2.93011593 |
| 162 | import into cell (GO:0098657) | 2.89524691 |
| 163 | eosinophil chemotaxis (GO:0048245) | 2.89346593 |
| 164 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.88771112 |
| 165 | negative regulation of interleukin-12 production (GO:0032695) | 2.88036602 |
| 166 | regulation of superoxide anion generation (GO:0032928) | 2.87590180 |
| 167 | positive regulation of cholesterol efflux (GO:0010875) | 2.86846528 |
| 168 | response to peptidoglycan (GO:0032494) | 2.86175796 |
| 169 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82961103 |
| 170 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.82246455 |
| 171 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.82038468 |
| 172 | lipid storage (GO:0019915) | 2.75060024 |
| 173 | angiotensin maturation (GO:0002003) | 2.74406281 |
| 174 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.71979956 |
| 175 | lytic vacuole organization (GO:0080171) | 2.71942711 |
| 176 | lysosome organization (GO:0007040) | 2.71942711 |
| 177 | regulation of intracellular pH (GO:0051453) | 2.71638018 |
| 178 | cellular extravasation (GO:0045123) | 2.71127413 |
| 179 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70571034 |
| 180 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.69076810 |
| 181 | positive regulation of macrophage cytokine production (GO:0060907) | 2.68970138 |
| 182 | biotin metabolic process (GO:0006768) | 2.67596442 |
| 183 | copper ion transport (GO:0006825) | 2.65364646 |
| 184 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.65172832 |
| 185 | regulation of cellular pH (GO:0030641) | 2.63650902 |
| 186 | stress fiber assembly (GO:0043149) | 2.63614639 |
| 187 | glycosphingolipid metabolic process (GO:0006687) | 2.61172891 |
| 188 | cellular iron ion homeostasis (GO:0006879) | 2.59011106 |
| 189 | plasma lipoprotein particle assembly (GO:0034377) | 2.58174658 |
| 190 | protein-lipid complex assembly (GO:0065005) | 2.55863995 |
| 191 | amino sugar metabolic process (GO:0006040) | 2.55125162 |
| 192 | positive regulation of macrophage differentiation (GO:0045651) | 2.54883807 |
| 193 | eosinophil migration (GO:0072677) | 2.54396320 |
| 194 | regulation of monocyte chemotaxis (GO:0090025) | 2.53319189 |
| 195 | alanine transport (GO:0032328) | 2.53128156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.89828269 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21192498 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.48105718 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.32921331 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.10878670 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.10861552 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.20214210 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.19435988 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.14985804 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.83654950 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61151284 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.55249946 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42182352 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.21672616 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.04887283 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.04618367 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00442978 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.59661274 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.32579056 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21828505 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.10788189 |
| 22 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.99501236 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.96147098 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.89497298 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.86901674 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81107002 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80999314 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80528033 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77520832 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67899019 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64630892 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64121645 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61495542 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60573132 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60540544 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60139195 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58330184 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54917114 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50420253 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50199064 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49807572 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49118341 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45780202 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44329777 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43991459 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.39754212 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39439756 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38183672 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36870215 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36130653 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33195994 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31419768 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27434251 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27350090 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27345183 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27237674 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26561856 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26161001 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25164525 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23791236 |
| 61 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.23657454 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22370722 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22103376 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21352840 |
| 65 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.19766202 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19002488 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17965830 |
| 68 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16922983 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16148236 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16041594 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15337995 |
| 72 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.14852371 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14742114 |
| 74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14512869 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14180969 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13419587 |
| 77 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13123169 |
| 78 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11378823 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10737510 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10391481 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09687794 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08911226 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08781763 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08416652 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07361624 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02752096 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01939230 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01378507 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99853073 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99092477 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98802878 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98548764 |
| 93 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.98181754 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98085199 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97661926 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95944573 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95934261 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95207573 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92941311 |
| 100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90658202 |
| 101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90658202 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90658202 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90023847 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89605484 |
| 105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89526958 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86551253 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85372131 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85372131 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85291714 |
| 110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85136586 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83858970 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82922292 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82379008 |
| 114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81464310 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81003165 |
| 116 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80563733 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79786562 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79384918 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78289156 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77639716 |
| 121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77579532 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77579532 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.76176531 |
| 124 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76047412 |
| 125 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75626683 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75537130 |
| 127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75488182 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74937245 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74628519 |
| 130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74447639 |
| 131 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.74350101 |
| 132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73628833 |
| 133 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73191844 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72926553 |
| 135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72505755 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71897779 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71893001 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70388148 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70109085 |
| 140 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.69410751 |
| 141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67568333 |
| 142 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67230084 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66896067 |
| 144 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.66099953 |
| 145 | KDM2B_26808549_Chip-Seq_K562_Human | 0.65964086 |
| 146 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65928913 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65394297 |
| 148 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65035823 |
| 149 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64089442 |
| 150 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63396341 |
| 151 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.63039918 |
| 152 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.62030029 |
| 153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60369275 |
| 154 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.60111153 |
| 155 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.59688107 |
| 156 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.59531369 |
| 157 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.59328856 |
| 158 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.58909062 |
| 159 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.58740903 |
| 160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.58455556 |
| 161 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.57946447 |
| 162 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.57409620 |
| 163 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.57286418 |
| 164 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57216498 |
| 165 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.56407398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.22449483 |
| 2 | MP0005360_urolithiasis | 6.43420089 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.25105392 |
| 4 | MP0005365_abnormal_bile_salt | 5.24847346 |
| 5 | MP0003172_abnormal_lysosome_physiology | 4.12714771 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.85628394 |
| 7 | MP0005310_abnormal_salivary_gland | 3.41035053 |
| 8 | MP0003252_abnormal_bile_duct | 3.36302560 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.01417766 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.00327293 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.98513016 |
| 12 | MP0003195_calcinosis | 2.94910125 |
| 13 | MP0003724_increased_susceptibility_to | 2.78462587 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.73926781 |
| 15 | MP0006082_CNS_inflammation | 2.71256952 |
| 16 | MP0005332_abnormal_amino_acid | 2.65662967 |
| 17 | MP0009840_abnormal_foam_cell | 2.51801931 |
| 18 | MP0005319_abnormal_enzyme/_coenzyme | 2.12701505 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.10284420 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.02024119 |
| 21 | MP0002419_abnormal_innate_immunity | 1.98008564 |
| 22 | MP0000609_abnormal_liver_physiology | 1.92850289 |
| 23 | MP0005083_abnormal_biliary_tract | 1.92423121 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.89651441 |
| 25 | MP0005220_abnormal_exocrine_pancreas | 1.87702551 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.85915012 |
| 27 | MP0000343_altered_response_to | 1.84385190 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.80862738 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.80424277 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.79384456 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.70518491 |
| 32 | MP0000537_abnormal_urethra_morphology | 1.70405597 |
| 33 | MP0003868_abnormal_feces_composition | 1.68279739 |
| 34 | MP0002998_abnormal_bone_remodeling | 1.66647061 |
| 35 | MP0001756_abnormal_urination | 1.64571247 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.62768427 |
| 37 | MP0003879_abnormal_hair_cell | 1.60370744 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.59091196 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.56303244 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.54936539 |
| 41 | MP0003075_altered_response_to | 1.54850084 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.54480766 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.54473692 |
| 44 | MP0005671_abnormal_response_to | 1.53372301 |
| 45 | MP0001727_abnormal_embryo_implantation | 1.52680609 |
| 46 | MP0000920_abnormal_myelination | 1.48540042 |
| 47 | MP0004858_abnormal_nervous_system | 1.42522454 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.39182665 |
| 49 | MP0000516_abnormal_urinary_system | 1.38547552 |
| 50 | MP0005367_renal/urinary_system_phenotyp | 1.38547552 |
| 51 | MP0003303_peritoneal_inflammation | 1.35273316 |
| 52 | MP0001765_abnormal_ion_homeostasis | 1.34299765 |
| 53 | MP0000579_abnormal_nail_morphology | 1.33638339 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.33042170 |
| 55 | MP0003011_delayed_dark_adaptation | 1.32426964 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31714289 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.30416579 |
| 58 | MP0001881_abnormal_mammary_gland | 1.26186183 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.26126490 |
| 60 | MP0004233_abnormal_muscle_weight | 1.23430499 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.22986209 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.22986209 |
| 63 | MP0001853_heart_inflammation | 1.22332898 |
| 64 | MP0003633_abnormal_nervous_system | 1.20871359 |
| 65 | MP0005025_abnormal_response_to | 1.20377630 |
| 66 | MP0003632_abnormal_nervous_system | 1.19998660 |
| 67 | MP0001764_abnormal_homeostasis | 1.19414872 |
| 68 | MP0005410_abnormal_fertilization | 1.18204218 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.17005498 |
| 70 | MP0004742_abnormal_vestibular_system | 1.16005404 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.15895468 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.15625034 |
| 73 | MP0009115_abnormal_fat_cell | 1.14711489 |
| 74 | MP0000598_abnormal_liver_morphology | 1.14433351 |
| 75 | MP0009785_altered_susceptibility_to | 1.12436060 |
| 76 | MP0003634_abnormal_glial_cell | 1.10037201 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.09845263 |
| 78 | MP0000569_abnormal_digit_pigmentation | 1.09421434 |
| 79 | MP0003436_decreased_susceptibility_to | 1.08512761 |
| 80 | MP0002229_neurodegeneration | 1.06628260 |
| 81 | MP0003631_nervous_system_phenotype | 1.06281127 |
| 82 | MP0004130_abnormal_muscle_cell | 1.05427446 |
| 83 | MP0002876_abnormal_thyroid_physiology | 1.04714255 |
| 84 | MP0003950_abnormal_plasma_membrane | 1.02772564 |
| 85 | * MP0002090_abnormal_vision | 1.02109121 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.02097862 |
| 87 | MP0009764_decreased_sensitivity_to | 0.98208870 |
| 88 | MP0001790_abnormal_immune_system | 0.93805730 |
| 89 | MP0005387_immune_system_phenotype | 0.93805730 |
| 90 | MP0000538_abnormal_urinary_bladder | 0.93351516 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.92724593 |
| 92 | MP0001533_abnormal_skeleton_physiology | 0.91383630 |
| 93 | MP0002971_abnormal_brown_adipose | 0.89974082 |
| 94 | MP0003690_abnormal_glial_cell | 0.89715827 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.89681086 |
| 96 | MP0008469_abnormal_protein_level | 0.89616170 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.89470601 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.89366576 |
| 99 | MP0001984_abnormal_olfaction | 0.88978024 |
| 100 | MP0002254_reproductive_system_inflammat | 0.88566875 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.87699736 |
| 102 | MP0000627_abnormal_mammary_gland | 0.87365850 |
| 103 | MP0002723_abnormal_immune_serum | 0.86123118 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.84955090 |
| 105 | MP0010307_abnormal_tumor_latency | 0.84129750 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.83988905 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.81605513 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.81322896 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.81297358 |
| 110 | MP0009278_abnormal_bone_marrow | 0.80984534 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.79414102 |
| 112 | MP0001944_abnormal_pancreas_morphology | 0.78727361 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.77690364 |
| 114 | MP0000613_abnormal_salivary_gland | 0.77342023 |
| 115 | MP0000462_abnormal_digestive_system | 0.76835931 |
| 116 | MP0005187_abnormal_penis_morphology | 0.76573975 |
| 117 | MP0002060_abnormal_skin_morphology | 0.76163355 |
| 118 | MP0009053_abnormal_anal_canal | 0.75890090 |
| 119 | MP0000604_amyloidosis | 0.73666954 |
| 120 | MP0000747_muscle_weakness | 0.72975905 |
| 121 | MP0002420_abnormal_adaptive_immunity | 0.72338716 |
| 122 | MP0001819_abnormal_immune_cell | 0.71816539 |
| 123 | MP0001661_extended_life_span | 0.70906544 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.70823462 |
| 125 | MP0002075_abnormal_coat/hair_pigmentati | 0.70395184 |
| 126 | MP0004147_increased_porphyrin_level | 0.69968427 |
| 127 | MP0001186_pigmentation_phenotype | 0.69447864 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.69334080 |
| 129 | MP0003795_abnormal_bone_structure | 0.68482785 |
| 130 | MP0001346_abnormal_lacrimal_gland | 0.66538338 |
| 131 | MP0001873_stomach_inflammation | 0.66493758 |
| 132 | MP0002089_abnormal_postnatal_growth/wei | 0.66378112 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.65903932 |
| 134 | MP0005408_hypopigmentation | 0.65790952 |
| 135 | MP0005334_abnormal_fat_pad | 0.65354854 |
| 136 | MP0003448_altered_tumor_morphology | 0.65152898 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.64026507 |
| 138 | MP0005451_abnormal_body_composition | 0.63869073 |
| 139 | MP0003936_abnormal_reproductive_system | 0.62879751 |
| 140 | MP0003329_amyloid_beta_deposits | 0.61439130 |
| 141 | MP0010368_abnormal_lymphatic_system | 0.61060485 |
| 142 | MP0005535_abnormal_body_temperature | 0.60942219 |
| 143 | MP0004036_abnormal_muscle_relaxation | 0.60853138 |
| 144 | MP0001919_abnormal_reproductive_system | 0.60825321 |
| 145 | MP0005257_abnormal_intraocular_pressure | 0.60822636 |
| 146 | MP0008874_decreased_physiological_sensi | 0.60562666 |
| 147 | MP0002127_abnormal_cardiovascular_syste | 0.60059382 |
| 148 | MP0003186_abnormal_redox_activity | 0.59056304 |
| 149 | MP0005647_abnormal_sex_gland | 0.58848346 |
| 150 | MP0009765_abnormal_xenobiotic_induced | 0.58808207 |
| 151 | MP0005330_cardiomyopathy | 0.56480289 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.56053759 |
| 153 | MP0005164_abnormal_response_to | 0.55890635 |
| 154 | MP0002896_abnormal_bone_mineralization | 0.54525322 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.54140246 |
| 156 | MP0003953_abnormal_hormone_level | 0.53984881 |
| 157 | MP0009763_increased_sensitivity_to | 0.51564609 |
| 158 | MP0009780_abnormal_chondrocyte_physiolo | 0.50653294 |
| 159 | MP0005166_decreased_susceptibility_to | 0.50256356 |
| 160 | MP0000371_diluted_coat_color | 0.49577182 |
| 161 | MP0002009_preneoplasia | 0.48618924 |
| 162 | MP0002135_abnormal_kidney_morphology | 0.47642733 |
| 163 | MP0002796_impaired_skin_barrier | 0.46812484 |
| 164 | MP0003942_abnormal_urinary_system | 0.46752948 |
| 165 | MP0005670_abnormal_white_adipose | 0.44627223 |
| 166 | MP0004947_skin_inflammation | 0.44061179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Shawl scrotum (HP:0000049) | 6.38194786 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.33231815 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.76263147 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.44598467 |
| 5 | Disinhibition (HP:0000734) | 5.31474907 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.18155967 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.04080300 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.99970557 |
| 9 | Loss of speech (HP:0002371) | 4.96372746 |
| 10 | Malnutrition (HP:0004395) | 4.93492108 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.88901751 |
| 12 | Neurofibrillary tangles (HP:0002185) | 4.44906023 |
| 13 | Xanthomatosis (HP:0000991) | 4.40852558 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.40338697 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.34819454 |
| 16 | Abnormality of the axillary hair (HP:0100134) | 4.33609591 |
| 17 | Abnormality of secondary sexual hair (HP:0009888) | 4.33609591 |
| 18 | Complement deficiency (HP:0004431) | 4.14755970 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14599732 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 4.13106790 |
| 21 | Long toe (HP:0010511) | 4.08459269 |
| 22 | Ileus (HP:0002595) | 4.05886377 |
| 23 | Abnormality of macrophages (HP:0004311) | 4.03760853 |
| 24 | Apathy (HP:0000741) | 3.96710660 |
| 25 | Diminished motivation (HP:0000745) | 3.92748657 |
| 26 | Axonal loss (HP:0003447) | 3.83443695 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.82306317 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.72159632 |
| 29 | Prostate neoplasm (HP:0100787) | 3.69096834 |
| 30 | Fat malabsorption (HP:0002630) | 3.68333178 |
| 31 | Joint hemorrhage (HP:0005261) | 3.67360328 |
| 32 | Agnosia (HP:0010524) | 3.59110279 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.55855198 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.55855198 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.55855198 |
| 36 | Ketosis (HP:0001946) | 3.55055203 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 3.52070248 |
| 38 | Aortic aneurysm (HP:0004942) | 3.51140239 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 3.47873096 |
| 40 | Cholecystitis (HP:0001082) | 3.47873096 |
| 41 | Hyperglycinemia (HP:0002154) | 3.46914176 |
| 42 | Hyperammonemia (HP:0001987) | 3.45552636 |
| 43 | Multiple enchondromatosis (HP:0005701) | 3.43800289 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.43234045 |
| 45 | Aplastic anemia (HP:0001915) | 3.41602480 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.40031806 |
| 47 | Mucopolysacchariduria (HP:0008155) | 3.40031806 |
| 48 | Aplasia of the musculature (HP:0100854) | 3.37161966 |
| 49 | Inappropriate behavior (HP:0000719) | 3.22070504 |
| 50 | Hypolipoproteinemia (HP:0010981) | 3.17804239 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 3.17251437 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17251437 |
| 53 | Abnormality of the periventricular white matter (HP:0002518) | 3.15198707 |
| 54 | Steatorrhea (HP:0002570) | 3.10919346 |
| 55 | Camptodactyly of toe (HP:0001836) | 3.09912648 |
| 56 | Mutism (HP:0002300) | 3.08118307 |
| 57 | Hyperglycinuria (HP:0003108) | 3.03312176 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 3.02513122 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.01401935 |
| 60 | Poor head control (HP:0002421) | 2.98416202 |
| 61 | Epidermoid cyst (HP:0200040) | 2.92565640 |
| 62 | Myopathic facies (HP:0002058) | 2.89284982 |
| 63 | Abnormality of complement system (HP:0005339) | 2.88617012 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87938800 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.86481611 |
| 66 | Sparse lateral eyebrow (HP:0005338) | 2.84731720 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.78138605 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.76201776 |
| 69 | Hyperventilation (HP:0002883) | 2.76032109 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.73829645 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73706794 |
| 72 | Hypoalphalipoproteinemia (HP:0003233) | 2.73696211 |
| 73 | Cholelithiasis (HP:0001081) | 2.73219517 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.71576327 |
| 75 | Agitation (HP:0000713) | 2.70860181 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.67369276 |
| 77 | Spastic diplegia (HP:0001264) | 2.66838016 |
| 78 | Gastrointestinal dysmotility (HP:0002579) | 2.65636459 |
| 79 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.64843171 |
| 80 | Hypoplastic nipples (HP:0002557) | 2.63653259 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.62652204 |
| 82 | Metaphyseal irregularity (HP:0003025) | 2.62246874 |
| 83 | Midline defect of the nose (HP:0004122) | 2.61495111 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.61309201 |
| 85 | Recurrent abscess formation (HP:0002722) | 2.60817381 |
| 86 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60253788 |
| 87 | Eczematoid dermatitis (HP:0000976) | 2.59322592 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 2.58993467 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56402316 |
| 90 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55513965 |
| 91 | Paralysis (HP:0003470) | 2.53418212 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 2.51732054 |
| 93 | Hypoglycemic coma (HP:0001325) | 2.51113777 |
| 94 | Blepharitis (HP:0000498) | 2.49632390 |
| 95 | Spontaneous abortion (HP:0005268) | 2.49421295 |
| 96 | Aortic dissection (HP:0002647) | 2.49059736 |
| 97 | Dementia (HP:0000726) | 2.48386119 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.45288243 |
| 99 | Stroke (HP:0001297) | 2.44496328 |
| 100 | Potter facies (HP:0002009) | 2.44254452 |
| 101 | Facial shape deformation (HP:0011334) | 2.44254452 |
| 102 | Cardiomegaly (HP:0001640) | 2.42535039 |
| 103 | Ketoacidosis (HP:0001993) | 2.42531230 |
| 104 | Menorrhagia (HP:0000132) | 2.40981638 |
| 105 | Infantile muscular hypotonia (HP:0008947) | 2.38624298 |
| 106 | Pancreatitis (HP:0001733) | 2.35868427 |
| 107 | Hypercholesterolemia (HP:0003124) | 2.34213292 |
| 108 | Pathologic fracture (HP:0002756) | 2.33156283 |
| 109 | Delayed CNS myelination (HP:0002188) | 2.32106666 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 2.32069813 |
| 111 | Hyperbilirubinemia (HP:0002904) | 2.30363036 |
| 112 | Breast hypoplasia (HP:0003187) | 2.30189041 |
| 113 | Nuclear cataract (HP:0100018) | 2.29957909 |
| 114 | Personality changes (HP:0000751) | 2.29318529 |
| 115 | Purpura (HP:0000979) | 2.23808736 |
| 116 | Protuberant abdomen (HP:0001538) | 2.23361072 |
| 117 | Joint contractures involving the joints of the feet (HP:0100492) | 2.20186919 |
| 118 | Flexion contracture of toe (HP:0005830) | 2.20186919 |
| 119 | Progressive neurologic deterioration (HP:0002344) | 2.17973150 |
| 120 | Esophageal varix (HP:0002040) | 2.17855348 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16992549 |
| 122 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.16059007 |
| 123 | Anal stenosis (HP:0002025) | 2.16017502 |
| 124 | Thoracic kyphosis (HP:0002942) | 2.16007111 |
| 125 | Hepatosplenomegaly (HP:0001433) | 2.14786471 |
| 126 | Hepatocellular carcinoma (HP:0001402) | 2.14494650 |
| 127 | Supranuclear gaze palsy (HP:0000605) | 2.13262878 |
| 128 | Right ventricular cardiomyopathy (HP:0011663) | 2.12255513 |
| 129 | Hemiplegia (HP:0002301) | 2.11668664 |
| 130 | Absent hand (HP:0004050) | 2.10974366 |
| 131 | J-shaped sella turcica (HP:0002680) | 2.09130732 |
| 132 | Global brain atrophy (HP:0002283) | 2.07490638 |
| 133 | Nausea (HP:0002018) | 2.06668155 |
| 134 | Dysphonia (HP:0001618) | 2.06347089 |
| 135 | Vascular calcification (HP:0004934) | 2.05768939 |
| 136 | Amyloidosis (HP:0011034) | 2.04898354 |
| 137 | Peripheral demyelination (HP:0011096) | 2.04298750 |
| 138 | Increased CSF protein (HP:0002922) | 2.03279942 |
| 139 | Cortical dysplasia (HP:0002539) | 2.01748740 |
| 140 | Gout (HP:0001997) | 2.01658216 |
| 141 | Abnormality of serum amino acid levels (HP:0003112) | 2.01197710 |
| 142 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.00459176 |
| 143 | Hypoplastic scapulae (HP:0000882) | 2.00459176 |
| 144 | Abnormality of glycolipid metabolism (HP:0010969) | 11.0284538 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 11.0284538 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 11.0284538 |
| 147 | Myocardial infarction (HP:0001658) | 1.98355217 |
| 148 | Aneurysm (HP:0002617) | 1.97272531 |
| 149 | Testicular atrophy (HP:0000029) | 1.95785346 |
| 150 | Abnormality of the prostate (HP:0008775) | 1.95730893 |
| 151 | Skin nodule (HP:0200036) | 1.95682212 |
| 152 | Abnormality of the gallbladder (HP:0005264) | 1.93467200 |
| 153 | Systemic lupus erythematosus (HP:0002725) | 1.91396603 |
| 154 | Status epilepticus (HP:0002133) | 1.91390204 |
| 155 | Abnormality of the Achilles tendon (HP:0005109) | 1.91329217 |
| 156 | Ectopia lentis (HP:0001083) | 1.91175851 |
| 157 | Multiple lipomas (HP:0001012) | 1.90383955 |
| 158 | Acanthocytosis (HP:0001927) | 1.88767422 |
| 159 | Abnormality of the lumbar spine (HP:0100712) | 1.88615714 |
| 160 | Irregular vertebral endplates (HP:0003301) | 1.88203273 |
| 161 | Esophageal neoplasm (HP:0100751) | 1.86887826 |
| 162 | Neoplasm of head and neck (HP:0012288) | 1.86887826 |
| 163 | Retinal atrophy (HP:0001105) | 1.84574256 |
| 164 | Generalized aminoaciduria (HP:0002909) | 1.83899996 |
| 165 | Fetal akinesia sequence (HP:0001989) | 1.83074078 |
| 166 | Mediastinal lymphadenopathy (HP:0100721) | 1.82732805 |
| 167 | Bone pain (HP:0002653) | 1.78093601 |
| 168 | Petechiae (HP:0000967) | 1.75655473 |
| 169 | Clumsiness (HP:0002312) | 1.68395984 |
| 170 | Azoospermia (HP:0000027) | 1.68317875 |
| 171 | Ragged-red muscle fibers (HP:0003200) | 1.66463671 |
| 172 | Albinism (HP:0001022) | 1.62743992 |
| 173 | Polyphagia (HP:0002591) | 1.58884878 |
| 174 | Increased serum ferritin (HP:0003281) | 1.58868914 |
| 175 | Oligomenorrhea (HP:0000876) | 1.58391710 |
| 176 | Abnormality of the odontoid process (HP:0003310) | 1.55903328 |
| 177 | Myoclonus (HP:0001336) | 1.54234127 |
| 178 | Abnormal cartilage morphology (HP:0002763) | 1.54218518 |
| 179 | Basal ganglia calcification (HP:0002135) | 1.53917648 |
| 180 | Abnormal neuron morphology (HP:0012757) | 1.52815495 |
| 181 | Abnormality of the motor neurons (HP:0002450) | 1.52815495 |
| 182 | Fasciculations (HP:0002380) | 1.52753982 |
| 183 | Hypoplasia of the odontoid process (HP:0003311) | 1.52540707 |
| 184 | Abnormality of the vertebral endplates (HP:0005106) | 1.51645083 |
| 185 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.51311941 |
| 186 | Hypokinesia (HP:0002375) | 1.50025616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.30774864 |
| 2 | BCKDK | 4.20397943 |
| 3 | PRKD3 | 3.26255838 |
| 4 | MYLK | 3.23382967 |
| 5 | DYRK3 | 3.12470607 |
| 6 | PDK2 | 2.91486167 |
| 7 | EEF2K | 2.72116076 |
| 8 | TAOK1 | 2.55221449 |
| 9 | ERN1 | 2.49310181 |
| 10 | CAMKK2 | 2.33619035 |
| 11 | PIK3CG | 2.20474361 |
| 12 | SIK1 | 2.15600386 |
| 13 | GRK7 | 2.15170767 |
| 14 | PIM2 | 2.06878911 |
| 15 | LATS1 | 2.05834862 |
| 16 | AKT3 | 10.3247153 |
| 17 | TNK2 | 1.89688107 |
| 18 | BLK | 1.88285667 |
| 19 | RIPK4 | 1.87682533 |
| 20 | TESK2 | 1.86563049 |
| 21 | ACVR1B | 1.86153953 |
| 22 | FRK | 1.75939493 |
| 23 | NEK9 | 1.69085128 |
| 24 | PTK6 | 1.67251330 |
| 25 | PRKD2 | 1.66456734 |
| 26 | NME2 | 1.66067397 |
| 27 | MAP2K7 | 1.62259345 |
| 28 | TRIB3 | 1.56755292 |
| 29 | ARAF | 1.56180090 |
| 30 | MAPKAPK3 | 1.46260959 |
| 31 | TTN | 1.45612366 |
| 32 | MAP3K2 | 1.45123436 |
| 33 | LIMK1 | 1.43724023 |
| 34 | MAP3K14 | 1.32289179 |
| 35 | TYK2 | 1.23793269 |
| 36 | PAK2 | 1.23328087 |
| 37 | PKN2 | 1.21312304 |
| 38 | GRK1 | 1.20081715 |
| 39 | MAP3K11 | 1.14035869 |
| 40 | SGK2 | 1.13565499 |
| 41 | MAP3K3 | 0.98353778 |
| 42 | STK39 | 0.95579501 |
| 43 | PIK3CA | 0.95307154 |
| 44 | MST1R | 0.94323792 |
| 45 | CSF1R | 0.89938594 |
| 46 | MAPK12 | 0.89706631 |
| 47 | CAMK1G | 0.88351114 |
| 48 | INSRR | 0.88266307 |
| 49 | FGR | 0.88106500 |
| 50 | ADRBK2 | 0.86725540 |
| 51 | FGFR4 | 0.84763215 |
| 52 | JAK2 | 0.83851851 |
| 53 | MAP3K1 | 0.83640461 |
| 54 | BMX | 0.83250538 |
| 55 | TAOK2 | 0.81732982 |
| 56 | DMPK | 0.81589453 |
| 57 | MAP3K13 | 0.80381318 |
| 58 | CSK | 0.78521895 |
| 59 | EIF2AK3 | 0.78196480 |
| 60 | RPS6KB2 | 0.77567546 |
| 61 | TESK1 | 0.76803888 |
| 62 | MAPK13 | 0.75667836 |
| 63 | TRPM7 | 0.71233571 |
| 64 | ICK | 0.70056313 |
| 65 | PDGFRA | 0.68437181 |
| 66 | IRAK3 | 0.66884201 |
| 67 | RIPK1 | 0.66387588 |
| 68 | MAP3K5 | 0.66130573 |
| 69 | SGK223 | 0.65145134 |
| 70 | SGK494 | 0.65145134 |
| 71 | CSNK1A1L | 0.65103941 |
| 72 | MAP2K4 | 0.64251244 |
| 73 | LRRK2 | 0.64176123 |
| 74 | MARK2 | 0.62539960 |
| 75 | NEK6 | 0.61481367 |
| 76 | MAP3K6 | 0.59274584 |
| 77 | MET | 0.58588791 |
| 78 | RPS6KB1 | 0.58435498 |
| 79 | PTK2 | 0.57998801 |
| 80 | CAMK1D | 0.57112408 |
| 81 | MOS | 0.55144941 |
| 82 | FER | 0.54829523 |
| 83 | MAP2K6 | 0.54512532 |
| 84 | MAP3K7 | 0.54408689 |
| 85 | PDPK1 | 0.53764147 |
| 86 | ERBB2 | 0.51614752 |
| 87 | RAF1 | 0.51394307 |
| 88 | JAK1 | 0.50336037 |
| 89 | PRKCZ | 0.50051799 |
| 90 | STK10 | 0.50005502 |
| 91 | MTOR | 0.49277365 |
| 92 | MAPK11 | 0.48962832 |
| 93 | PAK3 | 0.48489611 |
| 94 | CDC42BPA | 0.48136914 |
| 95 | FLT3 | 0.47375935 |
| 96 | NEK1 | 0.47179867 |
| 97 | GRK6 | 0.46762614 |
| 98 | TGFBR2 | 0.45621695 |
| 99 | LMTK2 | 0.43890047 |
| 100 | EPHB1 | 0.42273910 |
| 101 | RPS6KC1 | 0.40699617 |
| 102 | RPS6KL1 | 0.40699617 |
| 103 | MAPK7 | 0.39366227 |
| 104 | BRAF | 0.39208126 |
| 105 | CSNK1G3 | 0.38754115 |
| 106 | RET | 0.38639552 |
| 107 | EGFR | 0.37973446 |
| 108 | LYN | 0.37753571 |
| 109 | CAMK2G | 0.37747743 |
| 110 | MAP3K8 | 0.37584222 |
| 111 | GSK3A | 0.37545348 |
| 112 | LATS2 | 0.36871636 |
| 113 | CSNK1G2 | 0.36777346 |
| 114 | JAK3 | 0.36604863 |
| 115 | PDK1 | 0.36384744 |
| 116 | PDK4 | 0.34481019 |
| 117 | PDK3 | 0.34481019 |
| 118 | CAMK4 | 0.34441097 |
| 119 | DDR2 | 0.33540366 |
| 120 | IKBKB | 0.33435350 |
| 121 | FYN | 0.32306461 |
| 122 | RPS6KA2 | 0.31731063 |
| 123 | MAPKAPK5 | 0.31716223 |
| 124 | ZAP70 | 0.30943414 |
| 125 | RPS6KA6 | 0.30299995 |
| 126 | MAP2K1 | 0.30169653 |
| 127 | MARK1 | 0.28744180 |
| 128 | CSNK1A1 | 0.27774541 |
| 129 | ABL1 | 0.26963927 |
| 130 | TBK1 | 0.24752415 |
| 131 | NUAK1 | 0.24744101 |
| 132 | MARK3 | 0.23874752 |
| 133 | DYRK1B | 0.23333365 |
| 134 | ERBB4 | 0.22073079 |
| 135 | PRKAA2 | 0.21922731 |
| 136 | STK3 | 0.21136411 |
| 137 | MAP2K2 | 0.21009888 |
| 138 | ROCK1 | 0.20849207 |
| 139 | SCYL2 | 0.19849044 |
| 140 | FGFR2 | 0.18950562 |
| 141 | INSR | 0.18308265 |
| 142 | MAPK4 | 0.18097725 |
| 143 | MST4 | 0.17944202 |
| 144 | CAMK1 | 0.17459362 |
| 145 | ABL2 | 0.16763698 |
| 146 | PRKCH | 0.16705750 |
| 147 | NTRK1 | 0.15877831 |
| 148 | OXSR1 | 0.15510663 |
| 149 | PRKACB | 0.14988478 |
| 150 | MAP2K3 | 0.13205332 |
| 151 | MAP3K4 | 0.13118378 |
| 152 | PRKD1 | 0.12581965 |
| 153 | PDGFRB | 0.12326146 |
| 154 | SGK3 | 0.12009130 |
| 155 | DAPK2 | 0.11367552 |
| 156 | EPHA2 | 0.10610478 |
| 157 | IGF1R | 0.09964942 |
| 158 | IRAK2 | 0.09865671 |
| 159 | CAMKK1 | 0.09822099 |
| 160 | SRC | 0.08732235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.57691690 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.98498590 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91553263 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.78398770 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25598185 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06115758 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.05983843 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93068680 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.88261333 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.81516076 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.76336710 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.74550423 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.73586649 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40520713 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39356053 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 2.30780371 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29887111 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.29722045 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29437586 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26429093 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22509924 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.20042820 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.01039879 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.85088045 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.81964115 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.81918866 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80968564 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78756412 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77949739 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68180568 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.62630065 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.61762303 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60651806 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53739307 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.53726724 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53610753 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.51200798 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50882287 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49948799 |
| 40 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.48497222 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47903995 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43577733 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42656277 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.42242877 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.41744351 |
| 46 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.40165208 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37219346 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34311452 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27087212 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26261495 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22290332 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18844092 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16220576 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16114565 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14910488 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13271155 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12368840 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08884757 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08116735 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05929036 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04318642 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.99048302 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96590941 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.92561111 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.90489548 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88622432 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87975690 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87343075 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.85328489 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84715741 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84633403 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84163281 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82632282 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80009519 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77478145 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77312818 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76417743 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76009519 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75618883 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73535903 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.72400911 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69120396 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69115687 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.68525064 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.67056509 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66341484 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66048918 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65482357 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65385989 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64823424 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64261947 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60362602 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59038610 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58442167 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58312932 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57036582 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.56235673 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.56134808 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.51920358 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51869562 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51821436 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49314228 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46804927 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.46770469 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44450940 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43461376 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41721353 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41664974 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.39923560 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.39706844 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38150256 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38014224 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.37410720 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37198848 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35454075 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35422888 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32961907 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32185995 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32069727 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31737139 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30620643 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29578323 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29421020 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28611121 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28016704 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27824768 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25086544 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.25020371 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25009516 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21757522 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20949767 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19932224 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19468296 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19255799 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18832826 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18680572 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18441089 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17825244 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17326363 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.14237940 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12936393 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11254352 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10082150 |
| 144 | Salivary secretion_Homo sapiens_hsa04970 | 0.07490055 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.04326669 |
| 146 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03628825 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03494044 |
| 148 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.02435255 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01132342 |
| 150 | * Lysosome_Homo sapiens_hsa04142 | 0.00727181 |
| 151 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00547027 |
| 152 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.00455402 |
| 153 | Amoebiasis_Homo sapiens_hsa05146 | -0.0321369 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0292881 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0278915 |
| 156 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0200086 |
| 157 | Tight junction_Homo sapiens_hsa04530 | -0.0064193 |

